Evidence map›Paper›PMID 16354917›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2005

Brn3a-expressing retinal ganglion cells project specifically to thalamocortical and collicular visual pathways.

Lely A Quina, Winnie Pak, Jason Lanier, Premilla Banwait, Kevin Gratwick, Ying Liu, Tomoko Velasquez, Dennis D M O'Leary, Martyn Goulding, Eric E Turner

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 108 papers.

0numbers the graph read from it
0cells of the map it votes in
108citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

108 citing papers in PubMed, 170 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Development of the Binocular Circuit.Annual review of neuroscience · 2024
    Review
  6. Flp-recombinase mouse line for genetic manipulation of ipRGCs.bioRxiv : the preprint server for biology · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Characterization of Retinal Development in 13-Lined Ground Squirrels.Translational vision science & technology · 2022
    Article
  12. Article
  13. Tools and Biomarkers for the Study of Retinal Ganglion Cell Degeneration.International journal of molecular sciences · 2022
    Review
  14. Article
  15. Transcriptional Control of Axon Guidance at Midline Structures.Frontiers in cell and developmental biology · 2022
    Review
  16. A cell-ECM mechanism for connecting the ipsilateral eye to the brain.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Article

48 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Lely A QuinaDepartment of Psychiatry, University of California, San Diego, Veterans Affairs San Diego Healthcare System, La Jolla, California 92093-0603, USA.
Winnie Pak
Jason Lanier
Premilla Banwait
Kevin Gratwick
Ying Liu
Tomoko Velasquez
Dennis D M O'Leary
Martyn Goulding
Eric E Turner
Salk Institute for Biological Studies · USUniversity of California, San Diego · USVA San Diego Healthcare System · US

Funding

MECHANISMS GOVERNING DEVELOPMENT OF VISUAL CONNECTIONSR01EY007025 · NEI · WASHINGTON UNIVERSITY · PI O'LEARY, DENNIS D · 1986 to 2014
$8.9M
TRANSCRIPTION FACTORS IN CONTROL OF BRAIN DEVELOPMENTR01HD033442 · NICHD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TURNER, ERIC E. · 1997 to 2010
$2.5M
Developmental pathways in the nervous systemR01MH065496 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TURNER, ERIC E. · 2003 to 2007
$1.7M
NEI NIH HHS EY07025NEI NIH HHS R01 EY007025NICHD NIH HHS HD33442NICHD NIH HHS R01 HD033442NIMH NIH HHS MH065496NIMH NIH HHS R01 MH065496
6 · The paper itself

Abstract

Retinal ganglion cells (RGCs) innervate several specific CNS targets serving cortical and subcortical visual pathways and the entrainment of circadian rhythms. Recent studies have shown that retinal ganglion cells express specific combinations of POU- and LIM-domain transcription factors, but how these factors relate to the subsequent development of the retinofugal pathways and the functional identity of RGCs is mostly unknown. Here, we use targeted expression of an genetic axonal tracer, tau/beta-galactosidase, to examine target innervation by retinal ganglion cells expressing the POU-domain factor Brn3a. Brn3a is expressed in RGCs innervating the principal retinothalamic/retinocollicular pathway mediating cortical vision but is not expressed in RGCs of the accessory optic, pretectal, and hypothalamic pathways serving subcortical visuomotor and circadian functions. In the thalamus, Brn3a ganglion cell fibers are primarily restricted to the outer shell of the dorsal lateral geniculate, providing new evidence for the regionalization of this nucleus in rodents. Brn3a RGC axons have a relative preference for the contralateral hemisphere, but known mediators of the laterality of RGC axons are not repatterned in the absence of Brn3a. Brn3a is coexpressed extensively with the closely related factor Brn3b in the embryonic retina, and the effects of the loss of Brn3a in retinal development are not severe, suggesting partial redundancy of function in this gene class.

Indexed as

AnimalsAnimals, NewbornCerebral CortexGene Expression Regulation, DevelopmentalMaleMiceMice, Inbred C57BLMice, TransgenicRetinal Ganglion CellsSuperior ColliculiThalamic NucleiTranscription Factor Brn-3AVisual PathwaysTranscription Factor Brn-3A

Identifiers

PMID16354917
PMCPMC6726022
OpenAlexW2026358414

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.